Avacta signs diagnostic licensing deal with Biokit

Biokit is responsible for research, development and manufacturing of assays and biomaterial solutions for IVD use

picture of

Breaking News

Hubrecht Institute licenses reagent antibodies for cancer research

The Clevers group dedicates its activity to the study of the molecular mechanisms of tissue development and cancer of ...

Novasep expands Le Mans HPAPI manufacturing capacity

The company has been a partner to companies in the ADC arena for more than 15 years

Ingenza receives grant from Eureka and Innovate UK

The grant will support Ingenza as it aims to build a commercially viable P. putida bio-manufacturing pipeline

The CMO RFQ process and expectation management

Managing expectations during a request for quotation (RFQ) process is a crucial part of establishing a trustful and ...

Cell-based therapy specialist Solentim expands European operations

The England-based company has established a new EU entity based in Ireland to facilitate frictionless business within ...

Catalent acquires third facility in Belgium for pDNA manufacturing

CDMO Catalent has acquired liver disease specialist Promethera's cell therapy manufacturing subsidiary, including its ...

Beximco Pharma: The Bangladeshi company connecting with the US

COO Rabbur Reza talks about the strategy behind approaching pharmaceutical manufacturing from an emerging market

NerPharMa and ICROM partner on highly potent drugs and ADC-payloads

This agreement outlines the sharing of technologies, know-how, facilities and workforce of the two companies

AMRI expands capabilities across several sites

The expansion includes additional suites in New York, designed to manufacture batch sizes of 10-15 kilograms

Offer design and value-based pricing for CDMOs

Omar Ahmad, Kaan-Fabian Kekec and Niklas Fossum, from Simon-Kucher, explain how to grow sustainably through tiered ...

Addressing the need for cost-effective vaccine manufacturing

Process intensification and integrated continuous bioprocessing are two approaches that can be used to achieve cost- ...

Royal Society of Chemistry calls for R&D investment

The UK has fallen behind cohort nations in R&D investment, hampering efforts to boost productivity – with the impact ...

Vetter and Rentschler strengthen strategic alliance

The collaboration was initiated in 2020 with the intent to enable clients to bring their products to patients easier ...

Asher contracts ProBioGen to develop lead candidate

ProBioGen will now advance the development of Asher's lead candidate in immuno-oncology, applying its transposase ...